KKR to take Envision private for US$5.57 billion in healthcare push

KKR to take Envision private for US$5.57 billion in healthcare push

KKR & Co said on Monday it will take U.S. physician services provider Envision Healthcare Corp private in a deal valued at US$5.57 billion, its second major acquisition in less than two weeks.

FILE PHOTO:    CEO of Kohlberg Kravis Roberts & Co (KKR) Henry Kravis departs after meeting Ind
FILE PHOTO: CEO of Kohlberg Kravis Roberts & Co (KKR) Henry Kravis (C) departs after meeting India's Prime Minister Narendra Modi at a breakfast in the Manhattan borough of New York September 29, 2014. REUTERS/Carlo Allegri/File Photo

REUTERS: KKR & Co said on Monday it will take U.S. physician services provider Envision Healthcare Corp private in a deal valued at US$5.57 billion, its latest acquisition in the healthcare sector.

The private equity firm saw off competition from peers Carlyle Group , TPG Global and others as it sealed the deal for US$46 per share - a premium of 5.4 percent to Envision's last close on Friday.

Envision's shares were up 2.4 percent at US$44.7 in premarket trading. Including debt, the deal is valued at US$9.9 billion.

KKR already owns Envision's AMR, the largest U.S. provider of ambulance services, which it bought for US$2.4 billion last year and merged with its helicopter ambulance service. The firm also took WebMD Health Corp private for about US$2.8 billion.

Private equity firms, armed with a record US$1 trillion in cash, are investing more in public companies than at any time since the financial crisis.

So-called take-private deals worldwide reached a decade high of US$109 billion last year, according to data provided to Reuters from industry tracker Preqin.

KKR itself said last month it would buy business software company BMC Software, in a deal that could be worth about US$8.5 billion with debt, according to Reuters' sources.

As of March 31, KKR had US$176 billion in assets under management. It held US$1.88 billion in cash and cash equivalents, according to its latest earnings report.

In the healthcare industry, Envision's buyout is the latest in a spate of mergers and acquisitions activity among physician networks, a business that has struggled in recent years to adapt to changes in how U.S. health insurers reimburse providers.

Envision said the deal marks an end to its efforts to find strategic alternatives, which the company launched after posting disappointing third-quarter results last year. The company has been struggling with lower patient admissions at hospitals.

Ryan Daniels, an analyst with William Blair, said the purchase price was a fair multiple for Envision given a number of headwinds facing the industry. Daniels also cut the rating on Envision to "market perform", citing little to no possibility of other bidders emerging.

Reuters reported the deal on Sunday, citing a source. The deal is expected to close in the fourth quarter.

Envision was advised by J.P. Morgan, Evercore and Guggenheim Securities.

(Reporting By Aparajita Saxena in Bengaluru; Editing by Saumyadeb Chakrabarty)

Source: Reuters

Bookmark